Lab expands cancer tests

FORT MYERS - NeoGenomics has created new cancer tests that can help physicians monitor tumors without the need for tissue biopsies.

The liquid biopsy tests analyze blood plasma surrounding the tumors to monitor progression of certain types of cancers. NeoGenomics recently announced it has added two new tests that will help physicians monitor patients with certain kinds of lymphoma and leukemia.

Early detection of potential resistance may alert the treating physician to develop a new strategy for therapy or for a combination of therapies that may overcome resistance, the company says.